# Riley Rodgers

> Riley Rodgers is a Series A investor at MassChallenge backing Genetics and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [MassChallenge](https://shizune.co/investors/profile/masschallenge)
- Location: San Francisco, United States
- Total investments: 1
- Last investment: May 2018
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/rileyrodgers

Riley Rodgers is a Series A investor at MassChallenge in San Francisco focused on Genetics and Health Care. Riley Rodgers is the Principal at Valia Ventures.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Shield Bio | At Shield, we’re ensuring that antibiotic resistance doesn’t become more deadly than cancer.In 2050 more people will be dying of antibiotic resistant pathogens than cancer. Infections that were once treatable with a simple oral antibiotics are now requiring complex, painful treatments and resulting in serious health complications for patients.Gonorrhea is one such infection, having become resistant to over 10 different antibiotics, they have only one treatment that is still effective and resistance to this has already begun to emerge. With 820,000 new infections every year in the US, antibiotic resistance will spread quickly, which is why the CDC has resistant gonorrhea at an urgent threat level, the highest level available.Shield's novel genomic testing platform enables STI clinics to identify the antibiotic resistant strains of gonorrhea and other pathogens that their patients have, so they can select the correct antibiotics and halt the spread of antibiotic resistance. | $8M | Series A | May 23, 2018 |  |

1 of 1 investments shown.

## Co-investors
- [Arkitekt Ventures](https://shizune.co/investors/profile/arkitekt-ventures) — VC Fund, 1 deal together
- [Civilization Ventures](https://shizune.co/investors/profile/civilization-ventures) — VC Fund, 1 deal together
- [Esas Ventures](https://shizune.co/investors/profile/esas-ventures) — VC Fund, 1 deal together
- [Friále](https://shizune.co/investors/profile/friale) — VC Fund, 1 deal together
- [Tectonic Capital](https://shizune.co/investors/profile/fundersguild) — VC Fund, 1 deal together
- [iSelect Fund](https://shizune.co/investors/profile/iselectfund) — VC Fund, 1 deal together

## About MassChallenge

VC Fund · Boston, United States

MassChallenge works with founders developing solutions across sectors such as healthcare, climate, food systems, financial services, and security. It connects startups with corporate partners, investors, industry experts, and policymakers to facilitate business development and market entry. MassChallenge provides programming that includesmentorship, training, and access to resources that assist with product development, go-to-market strategy, and scaling operations. Its ecosystem integrates founders, advisors, and institutional partners to support company growth and advancement within complex industries.

5 contacts available at MassChallenge.

| Name | Title | Profile |
| --- | --- | --- |
| Antonio Procopio | Judge | https://shizune.co/investors/profile/antonio-procopio |
| Cait Brumme | Acting Chief Executive Officer | https://shizune.co/investors/profile/cait-brumme |
| Camila Lecaros | Managing Director | https://shizune.co/investors/profile/camila-lecaros |
| Charlotte Jepps | Expert & Accelerator Program Judge | https://shizune.co/investors/profile/charlotte-jepps |
| Chris Houlihan | Chief Growth Officer | https://shizune.co/investors/profile/chris-houlihan-31d8 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Riley Rodgers invest in?

Riley Rodgers invests primarily in Genetics, Health Care and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Riley Rodgers last invest?

The most recent investment recorded for Riley Rodgers closed in May 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co